Home > Naltrexone for the management of opioid dependence.

National Institute for Health and Clinical Excellence. [NICE] (2007) Naltrexone for the management of opioid dependence. London: NICE. NICE technology appraisal guidance 115

URL: http://guidance.nice.org.uk/TA115

Naltrexone is recommended as a treatment option for people who have been opioid dependent but who have stopped using opioids, and who are highly motivated to stay free from the drugs in an abstinence programme.

It should only be given to people who have been told about the problems associated with treatment, and with proper supervision. Treatment with naltrexone should be given as part of a support programme to help the person manage their opioid dependence.

Healthcare professionals should regularly review how well naltrexone is working to help people stay off opioids. If there is evidence that the person has been using the drugs again then healthcare professionals should consider stopping naltrexone treatment.


Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Opioid
Intervention Type:AOD disorder drug therapy
Source:NICE
Date:2007
Publisher:NICE
Corporate Creators:National Institute for Health and Clinical Excellence
Place of Publication:London
EndNote:View
Accession Number:HRB (Electronic Only)
Related URLs:
Subjects:HJ Treatment method > Treatment outcome
J Health care, prevention and rehabilitation > Health care administration > Health care quality control
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution)
B Substances > Opioids (opiates)
HJ Treatment method > Substance disorder treatment method > Substance disorder drug therapy

Repository Staff Only: item control page